Freneslerbart/ mevonlerbart
Monoclonal antibody
Also known as REGN1908, REGN1909
Evidence outlook · registrational
Allergic Conjunctivitis: registrational readout pending
No completed mid-stage readout is on record. Registrational readout expected around 2029-05-31.
Also in development:Cat Allergy · Phase 3
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
Featured-trial selection for this indication is pending.
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 3 (3)
What this study did
What this study did
What this study did
Phase 2 (1)
What this study did
Phase 1 (2)
What this study did
What this study did
Competitive landscape
This drug's own stage for Allergic Conjunctivitis: Phase 3. Competitors below are sorted furthest-along first.
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials | |
|---|---|---|---|---|---|---|
| Freneslerbart / Mevonlerbart: this drug | Phase 3 | Monoclonal antibody | Fel d 1 (major cat allergen protein) | not yet graded | No reviewed efficacy summary in this indication | |
| Dexamethasone (Dextenza) | Approved | Small molecule | Glucocorticoid receptor | not yet graded | No reviewed efficacy summary in this indication | |
| Reproxalap | Phase 3 | Small molecule | Reactive aldehyde species (RASP) | Partial signal | Featured results are non-efficacy only in this race |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow Freneslerbart/mevonlerbart to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2029 (1)
May 2029 (1)
What to watch
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent